The British Menopause Society Council aims to aid health professionals in providing up to date and informed advice about post reproductive health. This guidance refers to the long-term, but often ignored condition of urogenital atrophy resulting from postmenopausal estrogen deficiency. Treatment should be based on up to date information and targeted to the needs of the individual woman. Non-estrogen- and estrogen-containing treatments are discussed
Sex hormone deficiency in post-menopausal women causes changes in the lower urinary tract. Vulvovagi...
Menopause hormone therapy (MHT) is the most efficient treatment for symptoms of acute climacteric sy...
Modern management of the genitourinary syndrome of menopause (GSM) Abstract. Genitourinary syndrome ...
The British Menopause Society Council aims to aid health professionals in providing up to date and i...
Data are presented on the stages of aging of the female reproductive system and the symptoms develop...
Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting...
Estrogen deficit in postmenopausal women causes urogenital atrophy, which is responsible for a wide ...
Menopause represents an endocrine challenge to urogenital health, as oestrogens deprivation and andr...
Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for...
Symptoms and signs of the urogenital estrogen deficiency syndrome occur relatively late in a women's...
The term genitourinary syndrome of menopause was first used in 2014 by the North American Menopause ...
AbstractIntroductionVaginal atrophy, which may affect up to 45% of postmenopausal women, is often as...
The article presents a review of the literature, reflecting the modern aspects of the terminology, c...
Aim: Presentation of basic clinical scientific data based on modern evidence of anatomical and physi...
OBJECTIVE: To update and expand the previous position statement of The North American Menopause Soci...
Sex hormone deficiency in post-menopausal women causes changes in the lower urinary tract. Vulvovagi...
Menopause hormone therapy (MHT) is the most efficient treatment for symptoms of acute climacteric sy...
Modern management of the genitourinary syndrome of menopause (GSM) Abstract. Genitourinary syndrome ...
The British Menopause Society Council aims to aid health professionals in providing up to date and i...
Data are presented on the stages of aging of the female reproductive system and the symptoms develop...
Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting...
Estrogen deficit in postmenopausal women causes urogenital atrophy, which is responsible for a wide ...
Menopause represents an endocrine challenge to urogenital health, as oestrogens deprivation and andr...
Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for...
Symptoms and signs of the urogenital estrogen deficiency syndrome occur relatively late in a women's...
The term genitourinary syndrome of menopause was first used in 2014 by the North American Menopause ...
AbstractIntroductionVaginal atrophy, which may affect up to 45% of postmenopausal women, is often as...
The article presents a review of the literature, reflecting the modern aspects of the terminology, c...
Aim: Presentation of basic clinical scientific data based on modern evidence of anatomical and physi...
OBJECTIVE: To update and expand the previous position statement of The North American Menopause Soci...
Sex hormone deficiency in post-menopausal women causes changes in the lower urinary tract. Vulvovagi...
Menopause hormone therapy (MHT) is the most efficient treatment for symptoms of acute climacteric sy...
Modern management of the genitourinary syndrome of menopause (GSM) Abstract. Genitourinary syndrome ...
DOI
Add to ORKG